Business Wire

Arthur D. Little Delivers AV Market Insight in Latest Autonomous Mobility Journal

6.3.2023 15:00:00 EET | Business Wire | Press release

Share

Arthur D. Little (ADL) has published the fourth edition of its Autonomous Mobility Journal, which looks at the latest developments in autonomous vehicles (AVs) and the market for autonomous mobility going forward.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230306005447/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Arthur D. Little: Autonomous Mobility Journal, Fourth Edition (Graphic: Business Wire)

As well as highlighting current industry dynamics, the journal also includes:

  • A special focus on robotaxis around the world
  • An overview of the AV market in Hong Kong
  • An interview with Prof. Omaimah Bamasag, Deputy of Transport Enablement at the Transport General Authority of the Kingdom of Saudi Arabia

While the AV market remains in its infancy and, like other industries, has suffered setbacks due to the Covid-19 pandemic and semiconductor shortages, companies are still working hard to advance AV technologies to the point of mainstream acceptance and deployment. The buoyancy of the global electric vehicle (EV) market also provides a technology pathway for autonomous mobility features to be more readily adopted in the coming years.

An interesting aspect of the autonomous mobility landscape is the high number of start-ups in this space that have gone public through special-purpose acquisition companies (SPACs) rather than more conventional IPOs. Many of these companies have shown fragility and lack of resilience in a difficult market context – however, it is hoped that increased focus on EV innovation by major OEMs will create additional traction in the AV market, and boost the prospects of AV start-ups.

ADL believes that the outlook for robotaxis is more positive, with “city robotaxis” which can operate in any mapped area of a city, even in extreme weather conditions, likely by 2027. “Anywhere robotaxis”, which can operate on unmapped or unmade roads, could also be a reality by 2030.

ADL’s analysis of the AV market in Hong Kong reveals how it has positioned itself as a leader in the autonomous mobility ecosystem through the successful coordination of key elements, including strategy, regulations, stakeholder integration, infrastructure and technology. Finally, Prof. OmaimahBamasag outlines Saudi Arabia’s ambitious goals for AV transport, including major autonomy-based initiatives such as the Neom and Red Sea projects in the Kingdom’s economic zone.

Joseph Salem, Partner in ADL’s Travel & Transportation practice, comments: “While the development of autonomous mobility solutions globally remains experiential, industry players are clearly on the lookout for technological and business model innovation to unlock value-creating use cases. In this journal, we provide a realistic overview of recent developments and industry dynamics, including the key considerations and challenges that the AV market currently faces. We hope it provides food for thought and look forward to feedback from our readers.”

The journal is available for download here: https://tinyurl.com/24cr7dxj

For further information, please visit www.adlittle.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Cate Bonthuys / Sue Glanville
Catalyst Comms
+44 7746 546773
info@catalystcomms.co.uk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim2.9.2026 15:00:00 EEST | Press release

Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 15:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o

Croma-Pharma Introduces Electronic Instructions for Use Across the saypha ® Portfolio2.9.2026 14:37:00 EEST | Press release

Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requi

Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building2.9.2026 14:13:00 EEST | Press release

Across Oman, Orascom Development and its Sultanate platform, Muriya, are moving forward. While parts of the region grow cautious, Muriya has paused nothing, building and delivering across all three destinations: Hawana Salalah, Jebel Sifah and As Sodah Island. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902781576/en/ Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building (Photo: AETOSWire) The same steadiness runs through everything Samih Sawiris and Orascom have built, from El Gouna to Andermatt to Mamula Island: identifying extraordinary places and developing them for the long term. “Oman has everything we look for as a long-term developer: stability, natural beauty, and a clear direction for its future. Our continued investment across all three destinations reflects that conviction — we build for decades, and Oman is a country we intend to grow with in all circumstances.” — Naguib S. Sawiris, Chairm

Aukera Closes €460 Million Structured Credit Facility Led by EIG to Support European Energy Infrastructure Portfolio2.9.2026 14:00:00 EEST | Press release

Aukera, the pan-European battery storage and renewable energy platform backed by AtlasInvest, Reggeborgh and SFPIM (Belgium's sovereign wealth fund), announced the closing of its €460 million structured credit facility, for which EIG, a leading institutional investor in the global energy and infrastructure sectors, served as the lead investor. With the financing in place, Aukera moves into its next phase of growth, combining capital, expertise and delivery capability to build a significant European energy infrastructure platform that develops, finances, constructs and operates assets at scale. The original facility included an initial €200 million commitment and an accordion feature of up to €250 million. The amended facility converts that accordion into a firmly committed €260 million Series 2 tranche, increasing total committed capital to €460 million. The additional capital will support the continued advancement of Aukera's portfolio of renewable energy generation, battery storage a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye